Apex Biotechnology Corp.
1733
Rank in Stocks
#20350
Apex Biotechnology Corp. is a Taiwanese firm that specializes in the global... Apex Biotechnology Corp. is a Taiwanese firm that specializes in the global development, manufacturing, and distribution of medical devices designed for home use, all powered by sophisticated biosensor technology. Their comprehensive product lineup features a variety of personal health monitoring systems, including those for tracking blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1c, and ketone levels. In addition, the company provides self-testing solutions for coagulation and multi-parameter analysis, alongside advanced hemoglobin screening systems. Beyond patient diagnostics, Apex Biotech also offers systems for detecting pesticide residues. The company further extends its services to include digital care management and telehealth platforms. Established in 1997, Apex Biotechnology Corp. operates from its headquarters located in Hsinchu City, Taiwan.
Share Price
$0.86271018
Last synced: 2026-11-10
Market Cap
$86.23M
Change (1 day)
-1.57%
Change (1 year)
-18.26%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Apex Biotechnology Corp. (1733)
Category
Healthcare
EPS for Apex Biotechnology Corp. (1733)
EPS as of June 2026 TTM: $0.06
According to Apex Biotechnology Corp.'s latest financial reports, its current EPS (TTM) is $0.06. At the end of 2025 the company had an EPS of $0.05, an increase over its 2024 EPS of $0.04.
EPS history for Apex Biotechnology Corp. from 2009 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.06 | 17.40% |
| 2025 | $0.05 | 33.08% |
| 2024 | $0.04 | 3.17% |
| 2023 | $0.04 | -36.36% |
| 2022 | $0.06 | -18.85% |
| 2021 | $0.07 | 116.57% |
| 2020 | $0.03 | -11.29% |
| 2019 | $0.04 | 37.05% |
| 2018 | $0.03 | -4.14% |
| 2017 | $0.03 | 3,122.22% |
| 2016 | 0.00 | -98.89% |
| 2015 | $0.08 | -7.45% |
| 2014 | $0.09 | -30.82% |
| 2013 | $0.13 | -32.22% |
| 2012 | $0.19 | 2.36% |
| 2011 | $0.18 | 11.80% |
| 2010 | $0.16 | 52.63% |
| 2009 | $0.11 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | 26,578.02% |
US
|
|
| $-7.07 | -12,144.29% |
US
|
|
| $-5.29 | -9,111.93% |
AU
|
|
| $12.88 | 21,842.25% |
BE
|
|
| $21.56 | 36,629.13% |
NL
|
Questions about Apex Biotechnology Corp.'s earnings per share (EPS)
What is Apex Biotechnology Corp.'s earnings per share (EPS)?
Apex Biotechnology Corp.'s earnings per share (EPS) over the last twelve months is $0.06, as of Jun 2026.
What was Apex Biotechnology Corp.'s earnings per share (EPS) in 2025?
In 2025, Apex Biotechnology Corp.'s earnings per share (EPS) was $0.05, 25.00% more than in 2024 ($0.04).
How has Apex Biotechnology Corp.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Apex Biotechnology Corp.'s earnings per share (EPS) went from $0.03 to $0.05, an average growth of 10.76% a year.
How does Apex Biotechnology Corp.'s earnings per share (EPS) compare with similar companies?
Apex Biotechnology Corp.'s earnings per share (EPS) ($0.06) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.